Profil
Paula G.
O’Connor is Chief Medical Officer at Nurix Therapeutics, Inc. since 2024.
Formerly, Dr. O’Connor was Senior Vice President-Clinical Development at Protagonist Therapeutics, Inc. Education includes a doctorate from Stanford University School of Medicine and an undergraduate degree from Yale University.
Aktive Positionen von Paula O’Connor
| Unternehmen | Position | Beginn |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2022 |
Ehemalige bekannte Positionen von Paula O’Connor
| Unternehmen | Position | Ende |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2022 |
Ausbildung von Paula O’Connor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















